DAFTAR PUSTAKA
Alberti, K.G.M.M., Zimmet, P., Shaw, J., 2006. Metabolic Syndrome - A new world wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med, 23 : 469 – 480.
Anggara, F.H.D., Prayitno, N., 2013. Faktor – Faktor yang berhubungan dengan Tekanan darah di Puskesmas Telaga Murni, Cikarang Barat Tahun 2012. Jurnal Ilmiah Kesehatan, 5(1) : 20 – 25.
Armstrong, A.W., Lin, S.W., Chambers, C.J., Sockolov, M.E., Chin, D.L., 2011. Psoriasis and Hypertension Severity : Results from a Case-Control Study.
PLoS ONE, 6(3) : e18227.
Armstrong, E.P., Malone, D.C., 2003. The Impact of Non-steroidal Anti-inflammatory Drugs on Blood Pressure, with an Emphasis on Newer Agents. Clin Ther., 25 : 1 – 18.
Barnetson, R & White, A., 2006. Working in the tropics. In : Tyring, S.K., et al., eds. Tropical Dermatology. USA: Elsevier Inc, 22 – 26.
Bowcock, A.M., 2005. Understanding the pathogenesis of psoriasis, psoriatic arthritis, and autoimmunity via a fusion of molecular genetics and
immunology. Immunologic Research, 32: 45-46.
Canadian Hypertension Education Program, 2013. Accurate Measurement of Blood Pressure : Table 1. Recommended Technique for Measuring Blood
Pressure. Hypertension – Canada. Available From :
http://www.hypertension.ca/iframes/cheptables/table1.html?ml=1&ml=1&ml=
Cohen, A.D., Sherf, M., Vidavsky, L., Vardy, D.A., Shapiro, J., Meyerovitch, J., 2008. Association between Psoriasis and the Metabolic Syndrome. Dermatology, 216(2) : 152 – 155.
Department of Health and Human Services. 2003. The Seventh Report of The Joint National Committee on Prevention, Detection, Evaluation, and
Treatment of High Blood Pressure. The National Heart, Lung, and Blood Institute, The Executive Committee.
Djuanda, A., 2010. Dermatosis Eritroskuamosa. Dalam : Djuanda, A., ed. Ilmu Penyakit Kulit dan Kelamin. 6th ed. Jakarta: Balai Penerbit FK UI, 189-195.
Fisher, N.D.L. & Williams, G.H., 2005. Hypertensive Vascular Disease. In : Kasper, D.L., et al., eds. Harrison’s Principle of Internal Medicine. 16th ed.
USA: McGraw-Hill, 1466.
Ghazali, M.V., Sastromihardjo, S., Soedjarwo, S.R., Soelaryo, T., Pramulyo, H.S., 2008. Studi cross-sectional. Dalam : Sastroasmoro, S., Ismael, S., et al., eds. Dasar-dasar Metodologi Penelitian Klinis. Jakarta : Sagung Seto,
112-126.
Ghiasi, M., Nouri, M., Abbasi, A., Hatami, P., Abbasi, M.A., Nourijelyani, K., 2011. Psoriasis and increased prevalence of hypertension and diabetes mellitus. Indian J Dermatol, 56 : 533 – 536.
Griffiths, C.E. & Barker, J.N., 2007. Pathogenesis and Clinical Features of Psoriasis. Lancet, 370 : 263 – 271.
Gudjonsson, J.E. & Elder, J.T., 2008. Psoriasis. In : Wolff K., et al., eds. Fitzpatrick's Dermatology in General Medicine. 7th ed. USA: The
Hayashi, R., Yamashita, N., Matsui, S., Fujita, T., Araya, J., Sassa, K., Arai, N., Yoshida, Y., Kashii, T., Maruyama, M., Sugiyama, E., Kobayashi, M., 2000. Bradykinin stimulates IL-6 and IL-8 production by human lung fibroblasts through ERK- and p38 MAPK-dependent mechanisms. Eur Respir J, 16 : 452 – 458.
Huerta, C., Rivero, E., Rodriguez, L.A.G., 2007. Incidence and Risk Factors for Psoriasis in the General Population. Arch Dermatol, 143(12) : 1559-1565.
Huskic, J., Mulabegovic, N., Alendar, F., Ostojic, L., Ostojic, Z., Simic, D., Milicevic, R., Naletilic, M., 2008. Serum and Tissue Angiotensin Converting Enzyme in Patients with Psoriasis. Coll Antropol, 32 (4) : 1215-1219.
Icen, M., Crowson, C.S., McEvoy, M.T., Dann, F.J., et al., 2009. Trends in incidence of adult-onset psoriasis over three decades : a population based study. J Am Acad Dermatol, 60(3) : 394-401.
James, W.D., Berger, T.G., Elston, D.M., 2006. Andrew’s Diseases of the Skin.
10th ed. Philadelphia : Elsevier Inc, 193 – 201.
Kaplan, N.M., 2006. Kaplan’s Clinical Hypertension. 9th ed. Philadelphia : Lippincott Williams & Wilkins, 103 – 104.
Kranzhofer, R., Schmidt, J., Pfeiffer, C.A.H., Hagl, S., Libby, P. Kubler, W., 1999.
Angiotensin Induces Inflammatory Activation of Human Vascular Smooth
Muscle Cells. Available From:
http://atvb.ahajournals.org/content/19/7/1623.long [Accessed 22 Mei 2013].
Lee, C.T., Williams, G.H., Lilly, L.S., 2011. Hypertension. In : Lilly, L.S., ed. Pathophysiology of Heart Disease a collaborative project of medical
students and faculty. 5th ed. Philadelphia : Lippincott Williams & Wilkins,
301 – 323.
Madanagobalane, S., Anandan, S., 2012. Prevalence of Metabolic Syndrome in South Indian Patients with Psoriasis Vulgaris and the Relation Between Disease Severity and Metabolic Syndrome : A Hospital-Based
Case-Control Study. Indian J Dermatol, 57 : 353 – 357.
Mukhtar, Z., 2011. Desain Penelitian. Dalam : Mukhtar, Z., ed. Desain Penelitian Klinis dan Statistika Kedokteran. 1st ed. Medan : USU press, 72 – 75.
Murad, A & Tobin, A.M., 2012. Cardiovascular Disease in Inflammatory Disorders – Psoriasis and Psoriatic Arthritis. Available From : www.intechopen.com/download/pdf/32661 .
[Accessed 2 December 2013]
Naldi, L., Chatenoud, L., Belloni, A., Peserico, A., et al., 2005. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis : results from an Italian case-control study. J Invest Dermatol, 125: 61-67.
National Heart, Lung, and Blood Institute, 2010. What is Hypotension?. Available From : http://www.nhlbi.nih.gov/health/health-topics/topics/hyp/
[Accessed 2 December 2013]
Niehof, M. & Borlak, J., 2011. HNFalpha Dysfunction as a Molecular Rational for Cyclosporine Induced Hypertension. PLoS ONE, 6(1) : e16319.
Nestle, F.O., Kaplan, D.H., Barker, J., 2009. Mechanisms of disease Psoriasis. N
Rocha-Pereira, P., Santos-Silva, A., Rebelo, I., Figueiredo, A., Quintanilha, A., Teixeira, F., 2001. Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease. Clinica Chimica Acta, 303:
33-29.
Schön, M.P., Boehncke, W.H., 2005. Medical Progress Psoriasis. N Eng J Med, 352: 1899 – 1912.
Sherwood, L. 2010. Human Physiology from cells to systems. 7th ed. USA :
Cengage Learning, 350 – 351.
Siregar, R.S., 2000. Psoriasis. Dalam : Harahap, W., ed. Ilmu Penyakit Kulit. Jakarta : Hipokrates, 116 – 126.
Sowers, J.R., 2002. Hypertension, Angiotensin II, and Oxidative Stress. N Engl J
Med, 346: 1999–2001.
Strom, J.B., Libby, P., 2011. Atherosclerosis. In : Lilly, L.S., ed. Pathophysiology of Heart Disease a collaborative project of medical students and faculty. 5th ed. Philadelphia : Lippincott Williams & Wilkins, 113-134.
Sugiharto, A. 2007. Faktor-Faktor risiko Hipertensi grade II pada masyarakat (Studi Kasus di Kabupaten Karanganyar). Tesis. Semarang : Program Studi Epidemiologi Program Pasca Sarjana Universitas Diponegoro.
Tortora, G.J., Derrickson, B., 2012. The Cardiovascular System: Blood Vessels and Hemodynamics. In: Roesch, B., et al., eds. Principles of Anatomy and Physiology. 13th ed. USA: John Wiley & Sons, 817.
Tozawa, M., Oshiro, S., Iseki, C., Sesoko, S., Higashiuesato, Y., Tana, T., Ikemiya,Y., Iseki, K., Fukiyama, K., 2001. Family History of
Wakkee, M., Thio, H.B., Prens, E.P., Sijbrands, E.J.G., Neumann, H.A.M., 2007. Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients. Atherosclerosis, 190: 1 - 9.
